US Stock MarketDetailed Quotes

CLDX Celldex Therapeutics

Watchlist

27.440
-0.450-1.61%

Close Nov 29 13:00 ET

1.82BMarket Cap-10635P/E (TTM)

Celldex Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Celldex Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 433.330K	--
--	2024/Q4	-- / 1.307M	--
--	2024/Q3	3.191M / 1.074M	--
--	2024/Q2	2.498M / 854.290K	--
--	2024/Q1	156.000K / 816.670K	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 433.330K--

--2024/Q4-- / 1.307M--

--2024/Q33.191M / 1.074M--

--2024/Q22.498M / 854.290K--

--2024/Q1156.000K / 816.670K--

Unlock Free Earnings Estimates

Open Account

Celldex Therapeutics Earnings Reports

Celldex Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 6 16:07 ET

Celldex Therapeutics | 8-K: Celldex Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 6 16:02 ET

Celldex Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 8 16:57 ET

Celldex Therapeutics | 8-K: Celldex Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 8 16:49 ET

Analyst Rating

Updated: Nov 30, 2024

Strong Buy

Buy
81.82%
Hold
18.18%
Sell
0.00%

Price Target

No Data

Heat List

Overall